TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 72 filers reported holding TAYSHA GENE THERAPIES INC in Q1 2022. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $16,054,835 | -5.5% | 7,167,337 | +21.1% | 0.00% | – |
| Q1 2024 | $16,982,978 | +54.9% | 5,917,414 | -4.5% | 0.00% | – |
| Q4 2023 | $10,966,154 | -34.9% | 6,195,567 | +16.3% | 0.00% | – |
| Q3 2023 | $16,836,050 | +1502.7% | 5,327,864 | +235.2% | 0.00% | – |
| Q2 2023 | $1,050,493 | -16.8% | 1,589,248 | +0.4% | 0.00% | – |
| Q1 2023 | $1,262,950 | -64.1% | 1,583,438 | +1.8% | 0.00% | – |
| Q4 2022 | $3,515,805 | +70.1% | 1,555,666 | +45.3% | 0.00% | – |
| Q3 2022 | $2,067,000 | -48.1% | 1,070,802 | 0.0% | 0.00% | – |
| Q2 2022 | $3,983,000 | -39.6% | 1,070,802 | +5.8% | 0.00% | – |
| Q1 2022 | $6,599,000 | -35.9% | 1,012,164 | +14.5% | 0.00% | – |
| Q4 2021 | $10,295,000 | -31.4% | 883,647 | +9.7% | 0.00% | – |
| Q3 2021 | $15,002,000 | +12.6% | 805,718 | +28.2% | 0.00% | – |
| Q2 2021 | $13,327,000 | +42.6% | 628,644 | +36.6% | 0.00% | – |
| Q1 2021 | $9,343,000 | -24.3% | 460,248 | -1.0% | 0.00% | – |
| Q4 2020 | $12,337,000 | +634.3% | 464,850 | +519.8% | 0.00% | – |
| Q3 2020 | $1,680,000 | – | 75,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 2,000,000 | $53,080,000 | 57.48% |
| Octagon Capital Advisors LP | 320,440 | $8,504,000 | 2.95% |
| Alphabet Inc. | 640,882 | $17,009,000 | 0.82% |
| Casdin Capital, LLC | 820,440 | $21,774,000 | 0.64% |
| Artal Group S.A. | 1,040,882 | $27,625,000 | 0.59% |
| VR Adviser, LLC | 107,982 | $2,866,000 | 0.42% |
| Avidity Partners Management LP | 392,000 | $10,404,000 | 0.34% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $13,270,000 | 0.28% |
| Perceptive Advisors | 470,440 | $12,485,000 | 0.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 250,000 | $6,635,000 | 0.13% |